Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Posts 1 Percent Dip in Fiscal Q1 Revenues

NEW YORK (GenomeWeb News) – Accelrys yesterday reported a 1 percent decline in revenues for its first fiscal quarter as its net income improved over the year-ago period.

Accelrys said that revenues for the three months ended June 30 decreased to $20.1 million from $20.3 million in the prior-year period. The company attributed the decrease to a drop in maintenance revenue of around $400,000, which was partially offset by an increase in software revenue of around $300,000.

Net income increased to $744,000 from $86,000 in the comparable period of 2008.

Product development expenses decreased 9 percent to $3.9 million from $4.3 million in the year-ago period, while sales and marketing expenses remained flat at $8.1 million.

General and administrative expenses increased 6 percent to $3.7 million from $3.5 million for the three months ended June 30, 2008.

The company had cash, cash equivalents, marketable securities, and restricted cash of $83.7 million as of June 30.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.